104 related articles for article (PubMed ID: 22931672)
21. [The clinical efficacy and safety of itraconazole injection in treatment of invasive fungal infection in intensive care unit].
Collaborative Research Group of Itraconazole in Intensive Care Unit
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):414-7. PubMed ID: 20646417
[TBL] [Abstract][Full Text] [Related]
22. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
[TBL] [Abstract][Full Text] [Related]
23. Plasma Concentration of Itraconazole in Patients With Hematologic Malignancies Treated With Itraconazole Oral Solution.
Marumo A; Miyawaki S; Dan N; Ishiyama K
Ther Drug Monit; 2017 Jun; 39(3):229-234. PubMed ID: 28445212
[TBL] [Abstract][Full Text] [Related]
24. Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies.
Mattiuzzi GN; Alvarado G; Giles FJ; Ostrosky-Zeichner L; Cortes J; O'brien S; Verstovsek S; Faderl S; Zhou X; Raad II; Bekele BN; Leitz GJ; Lopez-Roman I; Estey EH
Antimicrob Agents Chemother; 2006 Jan; 50(1):143-7. PubMed ID: 16377679
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study.
Yoshida K; Kurashima A; Kamei K; Oritsu M; Ando T; Yamamoto T; Niki Y
J Infect Chemother; 2012 Jun; 18(3):378-85. PubMed ID: 22526387
[TBL] [Abstract][Full Text] [Related]
26. Outcome of empirical or targeted antifungal therapy after antifungal prophylaxis in febrile neutropenia.
Hahn-Ast C; Felder L; Mayer K; Mückter S; Ruhnke M; Hein R; Hellmich M; Schwab K; Rachow T; Brossart P; von Lilienfeld-Toal M
Ann Hematol; 2016 May; 95(6):1001-9. PubMed ID: 27021301
[TBL] [Abstract][Full Text] [Related]
27. [Cross-sectional investigation of first-choice of antifungal agents in empirical and preemptive antifungal therapy for patients with hematological malignancies].
Ji Y; Xu LP; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):473-7. PubMed ID: 23827099
[TBL] [Abstract][Full Text] [Related]
28. [An analysis of efficacy and related factors of itraconazole in the treatment of invasive fungal infection in hematological diseases].
Liu CY; Fu R; Wu YH; Ruan EB; Qu W; Wang GJ; Liang Y; Wang XM; Liu H; Song J; Guan J; Wang HQ; Xing LM; Li LJ; Wang J; Shao ZH
Zhonghua Nei Ke Za Zhi; 2010 Jun; 49(6):504-7. PubMed ID: 20979739
[TBL] [Abstract][Full Text] [Related]
29. Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis.
Kontoyiannis DP; Boktour M; Hanna H; Torres HA; Hachem R; Raad II
Cancer; 2005 Jun; 103(11):2334-7. PubMed ID: 15844093
[TBL] [Abstract][Full Text] [Related]
30. An open-label randomized trial comparing itraconazole oral solution with fluconazole oral solution for primary prophylaxis of fungal infections in patients with haematological malignancy and profound neutropenia.
Glasmacher A; Cornely O; Ullmann AJ; Wedding U; Bodenstein H; Wandt H; Boewer C; Pasold R; Wolf HH; Hänel M; Dölken G; Junghanss C; Andreesen R; Bertz H;
J Antimicrob Chemother; 2006 Feb; 57(2):317-25. PubMed ID: 16339606
[TBL] [Abstract][Full Text] [Related]
31. Successful empirical antifungal therapy of intravenous itraconazole with pharmacokinetic evidence in pediatric cancer patients undergoing hematopoietic stem cell transplantation.
Kim H; Shin D; Kang HJ; Yu KS; Lee JW; Kim SJ; Kim MS; Song ES; Jang MK; Park JD; Jang IJ; Park KD; Shin HY; Ahn HS
Clin Drug Investig; 2015 Jul; 35(7):437-46. PubMed ID: 26022135
[TBL] [Abstract][Full Text] [Related]
32. [Development of treatment adherence by jellification of itraconazole oral solution].
Wada H; Tanabe S; Ichikawa K; Sano F; Kubo Y; Matsuhashi Y; Nakanishi H; Tasaka T; Sugihara T
Jpn J Antibiot; 2009 Feb; 62(1):17-25. PubMed ID: 19378767
[TBL] [Abstract][Full Text] [Related]
33. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis.
Zhang YY; Zhou X;
Chin Med J (Engl); 2011 Oct; 124(20):3415-9. PubMed ID: 22088546
[TBL] [Abstract][Full Text] [Related]
35. [Effect of prophylaxis against myocosis in patients with hematological malignancy disease: efficacy of dosage of itraconazole].
Toubai T; Tanaka J; Fujisawa F; Kondo Y; Imamura M; Ota S; Hashino S; Yonetumi M; Chiba K; Kondo T; Toyoshima N; Asaka M
Jpn J Antibiot; 2003 Feb; 56(1):61-5. PubMed ID: 12723400
[TBL] [Abstract][Full Text] [Related]
36. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
[TBL] [Abstract][Full Text] [Related]
37. Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: a pilot study for evaluation of safety and efficacy.
Grigull L; Kuehlke O; Beilken A; Sander A; Linderkamp C; Schmid H; Seidemann K; Sykora KW; Schuster FR; Welte K
Pediatr Transplant; 2007 May; 11(3):261-6. PubMed ID: 17430480
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
[TBL] [Abstract][Full Text] [Related]
39. [The clinical study of invasive fungal infection in 76 cases of hematologic diseases].
Wu FF; Sun H; Gan SL; Ma J; Liu YF; Xie XS; Sun L; Liu LX; Wan DM
Zhonghua Nei Ke Za Zhi; 2013 Mar; 52(3):218-20. PubMed ID: 23856113
[TBL] [Abstract][Full Text] [Related]
40. Clinical experience with new formulation SUBA®-itraconazole for prophylaxis in patients undergoing stem cell transplantation or treatment for haematological malignancies.
Nield B; Larsen SR; van Hal SJ
J Antimicrob Chemother; 2019 Oct; 74(10):3049-3055. PubMed ID: 31360992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
